Searched for
ENTECAVIR
DRL, Zydus recall drugs in US over manufacturing issues: USFDADr Reddy's Laboratories and Zydus Lifesciences are recalling products in the US due to manufacturing issues. Dr Reddy's is recalling muscle...- Glenmark, Granules, Zydus recall products in US over manufacturing issues: USFDAIndian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- Cipla gets USFDA nod for Hepatitis B treatment drugThe tablets are generic versions of Bristol-Myers Suibb's Baraclude tablets of the same strength, Cipla said.
- Critical illness drugs remain unaffordableIn fact, prices of certain drugs like trastuzumab are negotiated by patients with distributors, and hence available at a 25-30% discount to...
- Blockbuster Hepatitis C drug now under price controlDrug-pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has brought under price control revolutionary drug 'Sofosbuvir' pres...
- The pill that costs $9,000 in US sells for $70 in IndiaAnd that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global...
- The pill that costs $9,000 in US sells for $70 in IndiaTypically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the ...
- IIFL’s 10 stock recommendations for Samvat 2072Inflation is well under control, not just due to subdued global commodities but also by virtue of disinflationary trends in domestic market.
- Aurobindo Pharma gets USFDA nod for hepatitis B drug EntecavirThe Hyderabad-based firm's approved abbreviated new drug application (ANDA) is therapeutically equivalent to Bristol-Myers Squibb's Baraclu...
- Rs 2,277 drug can treat hepatitis B patientsHepatitis B is transmitted through blood and infected bodily fluids. There is also a risk of infected mothers passing on the Hepatitis B vi...
- SMS, RTI potent tools of drug companies fighting patent battleInnovator drugmakers have started gleaning information from messages sent out by rival cos and websites of drug distributors to take a peek...
- Pharma MNCs use RTI law to protect market for patented drugs & delay entry of genericsMNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few month...
- Non-compliance with disclosure norms on patents may bring trouble for pharma companiesSeveral global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...
- HC rejects BMS’ plea on sale of hepatitis B generic by RanbaxyThe Delhi High Court (HC) has turned down Bristol-Myers Squibb’s (BMS) request to temporarily stop Ranbaxy from selling its generic version...
- Ranbaxy gets a reprieve in generic caseThe Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India’s Ranbaxy Laboratories from launchin...
Load More
